SynthesisFuture oncology (London, England)2025

Real-world avelumab first-line maintenance in advanced urothelial carcinoma: systematic review and meta-analysis.

Philippe Barthélémy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.